Martin H Bauermeister, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 17 Bay St, North Kingstown, RI 02852 Phone: 401-295-0370 |
Michael C Coburn, MD Psychiatry & Neurology - Addiction Medicine Medicare: Not Enrolled in Medicare Practice Location: 1950 Tower Hill Rd, North Kingstown, RI 02852 Phone: 401-559-3954 Fax: 401-294-4116 |
Anthony Louis Gallo Jr., MD Psychiatry & Neurology - Psychosomatic Medicine Medicare: Accepting Medicare Assignments Practice Location: 420 Scrabbletown Rd Ste A, North Kingstown, RI 02852 Phone: 401-268-5333 Fax: 401-268-5330 |
News Archive
In a recently published review article in the journal Drug Discovery Today, scientists have described the utility of human-based microphysiological systems MPSs in understanding the pathophysiology of SARS-CoV-2 infection and developing effective therapeutic interventions. Moreover, they have described the establishment of a global working group to synchronize recent developments around MPSs and COVID-19 research.
The U.S. Department of Health and Human Services (HHS) awarded $15 million of its $155-million total package to a team led by Susan Tortolero, Ph.D., director of the UTHealth Center for Health Promotion and Prevention Research.
Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.
More than a year after being diagnosed with a West Nile virus infection, half of the patients have ongoing health complaints including fatigue, memory problems, headaches, depression, and tremors, according to an article in the Sept. 15 issue of Clinical Infectious Diseases.
› Verified 8 days ago